Intermediolateral Nucleus (IML) Neurons
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Intermediolateral Nucleus (IML) Neurons</th> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Type </td> <td>Sympathetic Preganglionic Neurons</td> </tr> <tr> <td class="label">Location </td> <td>Spinal Cord Lateral Horn, T1-L2</td> </tr> <tr> <td class="label">Morphology </td> <td>Multipolar, dendrites in lamina VII</td> </tr> <tr> <td class="label">Neurotransmitter </td> <td>Acetylcholine</td> </tr> <tr> <td class="label">Marker Genes </td> <td>ChAT, Phox2b, Sim1, RVR</td> </tr> <tr> <td class="label">Gene</td> <td>Expression</td> </tr> <tr> <td class="label">ChAT</td> <td>High</td> </tr> <tr> <td class="label">Phox2b</td> <td>High</td> </tr> <tr> <td class="label">Sim1</td> <td>High</td> </tr> <tr> <td class="label">DBH</td> <td>Moderate</td> </tr> <tr> <td class="label">Target</td> <td>Approach</td> </tr> <tr> <td class="label">Spinal Cord Stimulation</td> <td>Modulate IML activity</td> </tr> <tr> <td class="label">Vagus Nerve Stimulation</td> <td>Autonomic regulation</td> </tr> <tr> <td class="label">Deep Brain Stimulation</td> <td>Hypothalamic targets</td> </tr> </table>
...
Intermediolateral Nucleus (IML) Neurons
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Intermediolateral Nucleus (IML) Neurons</th> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Type </td> <td>Sympathetic Preganglionic Neurons</td> </tr> <tr> <td class="label">Location </td> <td>Spinal Cord Lateral Horn, T1-L2</td> </tr> <tr> <td class="label">Morphology </td> <td>Multipolar, dendrites in lamina VII</td> </tr> <tr> <td class="label">Neurotransmitter </td> <td>Acetylcholine</td> </tr> <tr> <td class="label">Marker Genes </td> <td>ChAT, Phox2b, Sim1, RVR</td> </tr> <tr> <td class="label">Gene</td> <td>Expression</td> </tr> <tr> <td class="label">ChAT</td> <td>High</td> </tr> <tr> <td class="label">Phox2b</td> <td>High</td> </tr> <tr> <td class="label">Sim1</td> <td>High</td> </tr> <tr> <td class="label">DBH</td> <td>Moderate</td> </tr> <tr> <td class="label">Target</td> <td>Approach</td> </tr> <tr> <td class="label">Spinal Cord Stimulation</td> <td>Modulate IML activity</td> </tr> <tr> <td class="label">Vagus Nerve Stimulation</td> <td>Autonomic regulation</td> </tr> <tr> <td class="label">Deep Brain Stimulation</td> <td>Hypothalamic targets</td> </tr> </table>
Intermediolateral Nucleus (Iml) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview The Intermediolateral Nucleus (IML) is a column of neurons located in the lateral horn of the spinal cord, spanning primarily the thoracic and upper lumbar segments (T1-L2). The IML is the primary site for sympathetic preganglionic neurons that control autonomic functions including heart rate, blood pressure, respiration, and pupillary dilation. [@llewellynsmith2015]
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
Normal Function
Autonomic Control The IML is the central node for sympathetic nervous system control:
Cardiovascular : Heart rate, contractility, vasoconstriction
Respiratory : Bronchial tone, respiratory center modulation
Pupillary : Pupillary dilation via superior cervical ganglion
Sweat Glands : Sudomotor control
Preganglionic Output
Target : Peripheral autonomic ganglia
Neurotransmitter : Acetylcholine (nicotinic receptors)
Pathway : Spinal cord → preganglionic fiber → ganglion → postganglionic fiber
Neural Circuitry
Input : Visceral and somatic afferents, hypothalamic inputs
Integration : Receives descending sympathetic commands
Output : Sympathetic chain ganglia, collateral ganglia
Morphology and Markers
Morphological Features
Soma Size : Medium to large (30-50 μm diameter)
Dendritic Pattern : Dendrites extend into lamina VII
Axon : Long preganglionic axons in white rami communicantes
Organization : Columnar arrangement, segmentally repeated
Molecular Markers
ChAT : Choline acetyltransferase - acetylcholine synthesis
Phox2b : Transcription factor for autonomic neurons
Sim1 : Single-minded family bHLH transcription factor
RVR : Related to VENs (Reticulospinal)
Disease Vulnerability
Multiple System Atrophy (MSA)
Early Vulnerability : IML degeneration in MSA-C and MSA-P
Mechanism : Autonomic failure due to preganglionic neuron loss
Clinical Features : Orthostatic hypotension, bladder dysfunction
Parkinson's Disease
Dysautonomia : IML involvement in PD autonomic dysfunction
Mechanism : Lewy pathology in sympathetic preganglionic neurons
Clinical Features : Orthostatic hypotension, constipation
Amyotrophic Lateral Sclerosis (ALS)
Respiratory Failure : IML contributes to respiratory control
Mechanism : Motor neuron degeneration extends to autonomic regions
Clinical Features : Respiratory insufficiency
Pure Autonomic Failure
Selectivity : IML neurons selectively vulnerable
Mechanism : Unknown, possibly protein aggregation
Clinical Features : Severe orthostatic hypotension
Transcriptomic Profile
Key Marker Genes
Differentially Expressed Genes
Synaptic Proteins : For synaptic transmission
Ion Channels : For rhythmic firing
Metabolic Genes : High energy demand for continuous activity
Therapeutic Implications
Neuromodulation
Drug Development
Sympathomimetics : For orthostatic hypotension
Noradrenaline Reuptake Inhibitors : Midodrine, droxidopa
α2-Adrenergic Agonists : Clonidine modulation
Research Directions
Single-Cell Sequencing : Characterizing IML neuron subtypes
Circuit Mapping : Connectivity with brainstem and hypothalamus
Optogenetics : Controlling sympathetic output
Regeneration : Potential for cell replacement therapy
Key Publications
Strack AM, et al. (1988). Organization of spinal sympathetic neurons. J Comp Neurol . PMID: 3068282 (https://pubmed.ncbi.nlm.nih.gov/3068282/)
Llewellyn-Smith IJ, et al. (2015). Chemical phenotypes of sympathetic preganglionic neurons. Auton Neurosci . PMID: 25982874 (https://pubmed.ncbi.nlm.nih.gov/25982874/)
Benarroch EE, et al. (2010). Autonomic dysfunction in neurodegenerative diseases. Clin Auton Res . PMID: 20865632 (https://pubmed.ncbi.nlm.nih.gov/20865632/)
Kaufmann H, et al. (2020). Autonomic failure in MSA. Lancet Neurol . PMID: 32891214 (https://pubmed.ncbi.nlm.nih.gov/32891214/)
See Also
[Autonomic Nervous Systementities/autonomic-nervous-system)](/entities/autonomic-nervous-system)
[Multiple System Atrophy](/diseases/multiple-system-atrophy)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Spinal Cord](/brain-regions/spinal-cord)
[Sympathetic Nervous System](/genes/th)
](/mechanisms/spinal-cord
Show full description